Schizophrenia News and Research

Latest Schizophrenia News and Research

Social disadvantage may increase risk for psychosis

Results from a UK study suggest that social disadvantage is associated with an increased risk for developing psychosis.

25 Oct 2012

Axis I disorder risk increased in youth with parental history of BD

Children with a parental history of bipolar disorder are at increased for DSM-IV axis I disorders, research shows.

25 Oct 2012

BioLineRx intends to conduct interim analysis of BL-1020 Phase II/III trial for schizophrenia

BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.

25 Oct 2012

Neurofeedback enhances a brain network responsible for cognitive-control

A breakthrough study conducted in Canada has found that training of the well-known brainwave in humans, the alpha rhythm, enhances a brain network responsible for cognitive-control.

25 Oct 2012

Anterior insular cortex associated with human empathy

An international team led by researchers at Mount Sinai School of Medicine in New York has for the first time shown that one area of the brain, called the anterior insular cortex, is the activity center of human empathy, whereas other areas of the brain are not. The study is published in the September 2012 issue of the journal Brain.

25 Oct 2012

Roundup: States raise employee insurance contributions to save money; Minn. seeking $80M more for exchange; Selling insurance in malls

Financially strapped state and local governments are saving billions of dollars on health insurance by cutting back on free coverage for employees and raising worker contributions, a USA Today analysis finds. Government workers still enjoy more generous health benefits than privately employed workers but the advantage has narrowed from $1,523 in 2007 to $891 in 2012, adjusted for inflation, federal data show.

25 Oct 2012

Exendin-4 could effectively treat addiction

Vanderbilt researchers are reporting today that a drug currently used to treat type 2 diabetes could be just as effective in treating addiction to drugs, including cocaine.

24 Oct 2012

Link between autism spectrum disorders and schizophrenia

Autism Spectrum Disorders (ASD), a category that includes autism, Asperger Syndrome, and Pervasive Developmental Disorder, are characterized by difficulty with social interaction and communication, or repetitive behaviors. The U.S. Centers for Disease Control and Management says that one in 88 children in the US is somewhere on the Autism spectrum - an alarming ten-fold increase in the last four decades.

24 Oct 2012

Leg press power best indicator of function after knee arthroplasty

Leg press power is a better indicator of performance-based and self-reported functionality after total knee arthroplasty than knee extension strength, show study findings.

23 Oct 2012

Schizophrenia patients at increased death risk after AMI

Results from a Canadian study show that patients with schizophrenia are significantly more likely to die after acute myocardial infarction than other patients.

23 Oct 2012

Family functioning linked to disease course in adolescent BD

Family cohesion, adaptability, and conflict are associated with disease course in adolescent patients with bipolar disorder, US researchers report.

23 Oct 2012

Donor gene clue to kidney transplant rejection

Genetic study results show that long-term kidney transplant rejection risk may be increased if the organ donor has a variant form of the multidrug resistance 1 gene.

23 Oct 2012

Computed tomography aids scleroderma lung disease prognosis

High-resolution computed tomography is useful for the prognosis of patients with systemic scleroderma-related interstitial lung disease, research shows.

22 Oct 2012

$Ustekinumab success in refractory Crohn’s disease$